AQR Capital Management’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $297K | Buy |
+21,217
| New | +$297K | ﹤0.01% | 2880 |
|
|
2024
Q4 | – | Sell |
-16,018
| Closed | -$467K | – | 2890 |
|
|
2024
Q3 | $467K | Buy |
+16,018
| New | +$467K | ﹤0.01% | 2201 |
|
|
2024
Q2 | – | Sell |
-11,001
| Closed | -$226K | – | 2618 |
|
|
2024
Q1 | $226K | Buy |
+11,001
| New | +$226K | ﹤0.01% | 2230 |
|
|
2023
Q3 | – | Sell |
-8,165
| Closed | -$241K | – | 2330 |
|
|
2023
Q2 | $241K | Sell |
8,165
-1,036
| -11% | -$30.6K | ﹤0.01% | 2021 |
|
|
2023
Q1 | $212K | Buy |
+9,201
| New | +$212K | ﹤0.01% | 2038 |
|
|
2022
Q2 | – | Sell |
-22,686
| Closed | -$730K | – | 2203 |
|
|
2022
Q1 | $730K | Sell |
22,686
-28,981
| -56% | -$933K | ﹤0.01% | 1680 |
|
|
2021
Q4 | $2.3M | Sell |
51,667
-30,382
| -37% | -$1.35M | ﹤0.01% | 1090 |
|
|
2021
Q3 | $4.14M | Buy |
82,049
+2,765
| +3% | +$139K | 0.01% | 855 |
|
|
2021
Q2 | $6.22M | Sell |
79,284
-7,340
| -8% | -$576K | 0.01% | 789 |
|
|
2021
Q1 | $4.95M | Buy |
86,624
+22,757
| +36% | +$1.3M | 0.01% | 827 |
|
|
2020
Q4 | $5.35M | Buy |
63,867
+12,620
| +25% | +$1.06M | 0.01% | 763 |
|
|
2020
Q3 | $1.84M | Buy |
51,247
+22,370
| +77% | +$801K | ﹤0.01% | 1146 |
|
|
2020
Q2 | $698K | Buy |
28,877
+2,047
| +8% | +$49.5K | ﹤0.01% | 1621 |
|
|
2020
Q1 | $470K | Sell |
26,830
-22,375
| -45% | -$392K | ﹤0.01% | 1601 |
|
|
2019
Q4 | $857K | Sell |
49,205
-19,789
| -29% | -$345K | ﹤0.01% | 1563 |
|
|
2019
Q3 | $1.06M | Buy |
68,994
+58,648
| +567% | +$898K | ﹤0.01% | 1501 |
|
|
2019
Q2 | $215K | Buy |
+10,346
| New | +$215K | ﹤0.01% | 1964 |
|